Proactiveinvestors United Kingdom RNS press releases https://www.proactiveinvestors.co.uk Proactiveinvestors United Kingdom RNS press releases RSS feed en Sun, 25 Aug 2019 01:43:35 +0100 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) <![CDATA[RNS press release - Prelim Results for the year ended 30 April 2019 ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190731070009_14169476 Wed, 31 Jul 2019 07:00:09 +0100 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190731070009_14169476 <![CDATA[RNS press release - Use of Parsortix for single cell analysis of CTCs ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190722070006_14157190 Mon, 22 Jul 2019 07:00:06 +0100 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190722070006_14157190 <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190716091921_14150950 Tue, 16 Jul 2019 09:19:21 +0100 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190716091921_14150950 <![CDATA[RNS press release - Result of General Meeting anf Total Voting Rights ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190712102216_14146766 Fri, 12 Jul 2019 10:22:16 +0100 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190712102216_14146766 <![CDATA[RNS press release - Notice of Preliminary Results and Webcast ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190628133711_14129503 Fri, 28 Jun 2019 13:37:11 +0100 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190628133711_14129503 <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190628130845_14129475 Fri, 28 Jun 2019 13:08:45 +0100 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190628130845_14129475 <![CDATA[RNS press release - Result of Placing ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190625171909_14124214 Tue, 25 Jun 2019 17:19:09 +0100 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190625171909_14124214 <![CDATA[RNS press release - Accelerated bookbuild to raise £18.0m ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190625080233_14123174 Tue, 25 Jun 2019 08:02:33 +0100 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190625080233_14123174 <![CDATA[RNS press release - Parsortix used to investigate immunotherapy target ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190621070005_14119185 Fri, 21 Jun 2019 07:00:05 +0100 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190621070005_14119185 <![CDATA[RNS press release - Completion of Ovarian Cancer Pre-Study ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190605070010_14098743 Wed, 05 Jun 2019 07:00:10 +0100 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190605070010_14098743 <![CDATA[RNS press release - Positive Results from FDA Clinical Study ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190531070003_14093226 Fri, 31 May 2019 07:00:03 +0100 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190531070003_14093226 <![CDATA[RNS press release - IMMUNE SUPPRESSOR CELLS PROMOTE METASTASIS ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190426070008_14052748 Fri, 26 Apr 2019 07:00:08 +0100 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190426070008_14052748 <![CDATA[RNS press release - Parsortix used in new cancer assessment technique ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190418070008_14045574 Thu, 18 Apr 2019 07:00:08 +0100 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190418070008_14045574 <![CDATA[RNS press release - LUNG CANCER STUDY USES ANGLE'S PARSORTIX SYSTEM ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190412070006_14038627 Fri, 12 Apr 2019 07:00:06 +0100 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190412070006_14038627 <![CDATA[RNS press release - AACR 2019 ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190404070005_14028176 Thu, 04 Apr 2019 07:00:05 +0100 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190404070005_14028176 <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190311070011_13996486 Mon, 11 Mar 2019 07:00:11 +0000 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190311070011_13996486 <![CDATA[RNS press release - ENROLMENT COMPLETE FOR FDA CLINICAL STUDY ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190307070013_13993141 Thu, 07 Mar 2019 07:00:13 +0000 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190307070013_13993141 <![CDATA[RNS press release - FIRST SUBJECTS ENROLLED IN OVARIAN CANCER STUDY ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190228070022_13984463 Thu, 28 Feb 2019 07:00:22 +0000 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190228070022_13984463 <![CDATA[RNS press release - CUSTOMER DEMONSTRATES NEW USE FOR PARSORTIX ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190225070006_13979565 Mon, 25 Feb 2019 07:00:06 +0000 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190225070006_13979565 <![CDATA[RNS press release - Research into role of immune cells in cancer ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190211070005_13964083 Mon, 11 Feb 2019 07:00:05 +0000 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190211070005_13964083